Drug Chatter -- Tracking biopharma stock chatter

DrugPatentWatch - Biopharmaceutical Business Intelligence

Profile for Eleven Biotherapeutics, Inc. (EBIO)

« Back to company index

EBIO Chatter Timeline

Stock Ticker for EBIO

Most Active Tweeters for EBIO

UserTweets
@StockTexts 2
@Stock_News_Now 2

Recent Tweets for EBIO

Stock_News_Now @Stock_News_Now
$EBIO: New SEC Filing for EBIO: Form S-8 (No. 0001485003-19-000033): https://t.co/vTBVbvMjvA
May 21st 2019, 5:05pm
StockTexts @StockTexts
$EBIO Eleven Biotherapeutics, Inc. SEC Filing: Form S-8 https://t.co/5ygIaYgU6F
May 21st 2019, 4:05pm
Stock_News_Now @Stock_News_Now
$EBIO: New SEC Filing for EBIO: Form 8-K (No. 0001485003-19-000031): https://t.co/horChQu30E
May 13th 2019, 8:05am
StockTexts @StockTexts
$EBIO Eleven Biotherapeutics, Inc. SEC Filing: Form 8-K https://t.co/9zIUJC4p1O
May 13th 2019, 7:05am
Stock_News_Now @Stock_News_Now
$EBIO: New SEC Filing for EBIO: Form DEF 14A (No. 0001485003-19-000025): https://t.co/VdvHhXXZqz
April 30th 2019, 4:04pm
ExecPayOrg @ExecPayOrg
Eleven Biotherapeutics CEO Thomas Cannell receives $2.0M in 2018 https://t.co/dIOyKPCI0n $EBIO #execpay
April 30th 2019, 4:04pm
Stock_News_Now @Stock_News_Now
$EBIO: New SEC Filing for EBIO: Form PRE 14A (No. 0001485003-19-000021): https://t.co/OJf1fGgVvV
April 19th 2019, 4:04pm
StockTexts @StockTexts
$EBIO Eleven Biotherapeutics, Inc. SEC Filing: Form PRE 14A https://t.co/4Sa0tjdaTZ
April 19th 2019, 4:04pm
Ultra_Calls @Ultra_Calls
$SESN 1.18 dip buy could be a good entry for a swing. Former $EBIO
April 18th 2019, 9:04am
StockTexts @StockTexts
$EBIO Eleven Biotherapeutics, Inc. SEC Filing: Form 3 https://t.co/MzaD7tmx7A
April 15th 2019, 9:04pm
confcalltran @confcalltran
Eleven Biotherapeutics's Chief Technology Officer just declared 588,776 options https://t.co/adzWqcBwKJ $EBIO
April 15th 2019, 8:04pm
SmallCaps33 @SmallCaps33
https://t.co/TGJvsvq10N Get your trial for free to this top trading teachers chatroom! Ends soon! $TRTC $EBIO #stocks #trading
March 27th 2019, 7:03am
StockTexts @StockTexts
$EBIO Eleven Biotherapeutics, Inc. SEC Filing: Form 8-K https://t.co/9lqC5NGI13
March 4th 2019, 7:03am
Stock_News_Now @Stock_News_Now
$EBIO: New SEC Filing for EBIO: Form 10-K (No. 0001485003-19-000015): https://t.co/uoWL7UCpfi
March 1st 2019, 5:03pm
confcalltran @confcalltran
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or https://t.co/Q4M2YWREyP $EBIO
February 25th 2019, 4:02pm
confcalltran @confcalltran
Eleven Biotherapeutics's Chief Financial Officer was just granted 178,500 options https://t.co/cLG5h1UIik $EBIO
February 25th 2019, 4:02pm
confcalltran @confcalltran
Eleven Biotherapeutics's President and CEO was just granted 1,000,000 options https://t.co/5MBw2bFjQD $EBIO
February 25th 2019, 4:02pm

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2019. All rights reserved.